header
Image from OpenLibrary

Treatment outcome of pediatric hodgkin's lymphoma at the national cancer institute (NCI) / Hani Hemmat Abdelmonem Abdelhamid ; Supervised Iman A. Sidhom , Iman A. Attia , Amr M. Amin

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Hani Hemmat Abdelmonem Abdelhamid , 2015Description: 195 P. : facsimiles ; 25cmOther title:
  • نتائج علاج سرطان الغدد الليمفاوية (هودجكن) لدى الأطفال في المعهد القومي للاورام - جامعة القاهرة [Added title page title]
Subject(s): Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (M.Sc.) - Cairo University - National Cancer Institute - Department of Pediatric Oncology Summary: Hodgkin lymphoma (HL) accounts for 8% to 10% of all childhood cancer. It displays characteristic epidemiological, clinical, and pathological features according to various geographic areas. We aimed to assess the epidemiological aspects, clinicopathological features, and treatment outcome of pediatric HL treated at Pediatric Oncology Department, National Cancer Institute, Cairo University. We carried a retrospective study by reviewing medical records for all patients admitted with the diagnosis of HL over 5 years during the period between January 2008 till end of December 2012, and they were followed up till the end of December 2013. Age of the patients at presentation ranged from 3 to 18 years (median 11 years) and male: female ratio 1.6:1. Cervical lymphadenopathy was the most common presentation (94.8%). Mixed cellularity subtype was dominant (44.7%), followed by nodular sclerosis (34.3%), lymphocyte-rich (10.4%) with lymphocyte depletion being the least dominant (3.7%). About half of patients (45.5 %) had advanced disease (Ann Arbor stage III/IV disease). The duration of follow-up ranged from 6 to 56.5 months (median 35.8 months). The 5-year overall survival and event-free survival for patients were 94% and 79% respectively
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Date due Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.19.05.M.Sc.2015.Ha.T (Browse shelf(Opens below)) Not for loan 01010110067887000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.19.05.M.Sc.2015.Ha.T (Browse shelf(Opens below)) 67887.CD Not for loan 01020110067887000

Thesis (M.Sc.) - Cairo University - National Cancer Institute - Department of Pediatric Oncology

Hodgkin lymphoma (HL) accounts for 8% to 10% of all childhood cancer. It displays characteristic epidemiological, clinical, and pathological features according to various geographic areas. We aimed to assess the epidemiological aspects, clinicopathological features, and treatment outcome of pediatric HL treated at Pediatric Oncology Department, National Cancer Institute, Cairo University. We carried a retrospective study by reviewing medical records for all patients admitted with the diagnosis of HL over 5 years during the period between January 2008 till end of December 2012, and they were followed up till the end of December 2013. Age of the patients at presentation ranged from 3 to 18 years (median 11 years) and male: female ratio 1.6:1. Cervical lymphadenopathy was the most common presentation (94.8%). Mixed cellularity subtype was dominant (44.7%), followed by nodular sclerosis (34.3%), lymphocyte-rich (10.4%) with lymphocyte depletion being the least dominant (3.7%). About half of patients (45.5 %) had advanced disease (Ann Arbor stage III/IV disease). The duration of follow-up ranged from 6 to 56.5 months (median 35.8 months). The 5-year overall survival and event-free survival for patients were 94% and 79% respectively

Issued also as CD

There are no comments on this title.

to post a comment.